Idiopathic Pulmonary Fibrosis Job Exposures Study
Studying Idiopathic pulmonary fibrosis
Last synced from ClinicalTrials.gov
Key facts
- Sponsor
- Imperial College London
- Principal Investigator
- Carl Reynolds, MDImperial College London
- Intervention
- Computer-assisted telephone interview(other)
- Enrollment
- 960 enrolled
- Eligibility
- MALE
- Timeline
- 2017 – 2019
Study locations (1)
- Imperial Healthcare NHS Trust, London, United Kingdom
Collaborators
Wellcome Trust · University Hospital Southampton NHS Foundation Trust · Imperial College Healthcare NHS Trust · Heart of England NHS Foundation Trust · Liverpool University Hospitals NHS Foundation Trust · Papworth Hospital NHS Foundation Trust · Nottingham University Hospitals NHS Trust · University Hospital of South Manchester · Guy's and St Thomas' NHS Foundation Trust · North Bristol NHS Trust · The Leeds Teaching Hospitals NHS Trust · Newcastle-upon-Tyne Hospitals NHS Trust · Royal Devon and Exeter NHS Foundation Trust · Somerset NHS Foundation Trust · Royal Infirmary of Edinburgh · Morriston Hospital · Aberdeen Royal Infirmary · Worcestershire Acute Hospitals NHS Trust · University Hospital Birmingham NHS Foundation Trust · Portsmouth Hospitals NHS Trust · Norfolk and Norwich University Hospitals NHS Foundation Trust · Glasgow Royal Infirmary
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03211507 on ClinicalTrials.govOther trials for Idiopathic pulmonary fibrosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT05988463Dose-Escalation Study of Artesunate Patients With IPFJoseph C. Wu
- RECRUITINGPHASE2NCT07572383Advanced Imaging to Assess the Effect of Immunosuppression on Progressive FibrosisPeter Caravan
- RECRUITINGNANCT07486206Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 TrialHospital de Granollers
- RECRUITINGNANCT07482917Optimizing the Diagnostic Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-1 TrialHospital de Granollers
- RECRUITINGPHASE2NCT06241560A Study in People With Idiopathic Pulmonary Fibrosis to Test Whether Pirfenidone Influences the Amount of BI 1015550 in the BloodBoehringer Ingelheim
- RECRUITINGPHASE3NCT07201922A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary FibrosisBoehringer Ingelheim
- RECRUITINGPHASE2NCT06968845A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary FibrosisRein Therapeutics
- ENROLLING BY INVITATIONNCT06885515Telomeres Length in Israeli Fibrotic ILD PatientsBarzilai Medical Center